Utilize este identificador para referenciar este registo:
|Título:||Novel tacrine derivatives that block neuronal calcium channels|
|Autor:||de los Rios, C|
|Palavras-chave:||Biochemistry & Molecular Biology|
|Editora:||PERGAMON-ELSEVIER SCIENCE LTD|
|Citação:||BIOORGANIC & MEDICINAL CHEMISTRY. - Vol. 10, n. 6 (JUN 2002), p. 2077-2088|
|Resumo:||A new series of tacrine (9-amino-1,2,3,4-tetrahydroacridine) derivatives were synthesized and their effects on Ca-45 (2+) entry into bovine adrenal chromaffin cells stimulated with dimethylphenylpiperazinium (DMPP) or K+, studied. At 3 PM, compound 1 did not affect Ca-45(2+) uptake evoked by DMPP. Compounds 14, 15 and 17 inhibited the effects of DMPP by 30%. Compounds 3, 9 and tacrine blocked the DMPP signal by about 50%. Compounds 5 and 12 were the most potent blockers of DMPP-stimulated (45)Ca2(+) entry (90%); the rest of the compounds inhibited the effects of DMPP by 70-80%. Compounds 1, 3, 4, 8, 10, If, 13, 16, 17 and tacrine inhibited Ca-45(2+) Uptake induced by K+ about 20%. Compounds 6. 14 and 15 inhibited the K+ effects by 10% or less. Compounds 7, 9, 12 and 18 blocked the K+ signal by 30% and, finally, compounds 2 and 5 inhibited the K+-induced Ca-45(2+) entry by 50%, None of the new compounds was as effective as diltiazem (IC50 0.03 muM) in causing relaxation of the rat aorta precontracted with 35 mM K+; the most potent was compound 7(IC50 = 0.3 muM). Compounds 5, 6, 8, 9, 10 and 13 had IC(50)s around 10 muM and compounds 3, 4, 11 and 12 around 20 muM. Blockade of Ca2+ entry through neuronal voltage-dependent Ca2+ channels, without concomitant blockade of vascular Ca2+ channels, suggests that some of these compounds might exhibit neuroprotectant effects but not undesirable hemodynamic effects. (C) 2002 Elsevier Science Ltd. All rights reserved.|
|Aparece nas colecções:||FF - Produção Científica 2000-2009|
Ficheiros deste registo:
Não existem ficheiros associados a este registo.
Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.